Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 serostatus of healthcare worker in the Austrian state Vorarlberg between June 2020 and January 2021

Michele Atzl, Axel Muendlein, Thomas Winder, Peter Fraunberger, Eva-Maria Brandtner, Kathrin Geiger, Miriam Klausberger, Mark Duerkop, Lukas Sprenger, Beatrix Mutschlechner, Andreas Volgger, Magdalena Benda, Luciano Severgnini, Johannes B. Jaeger, Heinz Drexel, Alois Lang, View ORCID ProfileAndreas Leiherer
doi: https://doi.org/10.1101/2021.02.19.21252045
Michele Atzl
1Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel Muendlein
2Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Winder
1Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Fraunberger
3Medical Central Laboratories, Feldkirch, Austria
4Private University of the Principality of Liechtenstein, Triesen, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva-Maria Brandtner
2Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathrin Geiger
2Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
3Medical Central Laboratories, Feldkirch, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam Klausberger
5Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU) Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Duerkop
5Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU) Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lukas Sprenger
1Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
2Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatrix Mutschlechner
1Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
4Private University of the Principality of Liechtenstein, Triesen, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Volgger
1Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magdalena Benda
1Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luciano Severgnini
1Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes B. Jaeger
1Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heinz Drexel
2Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
4Private University of the Principality of Liechtenstein, Triesen, Liechtenstein
6Department of Internal Medicine, Academic Teaching Hospital Bregenz, Bregenz, Austria
7Drexel University College of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alois Lang
8Cancer Registry Vorarlberg, Agency for Preventive and Social Medicine, Bregenz Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Leiherer
2Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
3Medical Central Laboratories, Feldkirch, Austria
4Private University of the Principality of Liechtenstein, Triesen, Liechtenstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andreas Leiherer
  • For correspondence: vivit@lkhf.at
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Austria, and particularly its westernmost federal state Vorarlberg, developed the highest COVID-19 incidence rate worldwide in November 2020. Health care workers (HCW) may be at higher risk of contracting the disease within the working environment and therefore the seroprevalence in this population is of particular interest. Here, we analyzed SARS-CoV-2-specific antibody response in Vorarlberg HCW in a prospective cohort study.

Methods A total of 395 HCW have been tested at three different time points for the prevalence of anti-SARS-CoV-2 IgG antibodies specific for NP and RBD. Enrollment started in June 2020 (t1), two months after the end of the first wave. Re-testing took place between October to November at the beginning of the second wave (t2), and again at the end of the second wave in January 2021(t3).

Results At t1, 3% of HCW showed a strong IgG-specific responses to either NP or RBD. At t2, the rate increased to 4%, and after the second wave in January 2021, 14% had a strong response, which was assessed to be stable for up to ten months. The amount of HCW with anti-SARS-CoV-2 IgG antibodies was 38% higher than the number of infections found by PCR.

Conclusion We found low numbers of SARS-CoV-2-seropositive HCW in a hotspot setting after the first wave but a massive increase during the second wave distinctly surpassing the number of infected HCW identified by PCR. Our findings, therefore, offer support for the routine application of serological testing in management of the ongoing COVID-19 pandemic.

Main summary A relatively low percentage of 3% SARS-CoV-2 seropositive HCW with strong IgG-specific antibody responses was found in the Austrian federal state Vorarlberg after the first wave increasing to 14% after the second massive wave lasting until January 2021.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

no clinical trial

Funding Statement

This work received a particular funding from the Austrian FFG (project number 880956).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Th study has been approved by the Ethics Committee of Vorarlberg (EK-2-4/2020).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding and disclosures This work received a particular funding from FFG (project number 880956). No potential conflicts of interest relevant to this article were reported by M.A., A.M., T.W., P.F., E.M.B., K.G., M.K., M.D., L.Sp., B.M., A.V., M.B., L.Se., J.J., H.D., A.La., and A.Le..

  • Data sharing statement The data that support the findings of this study are available from the corresponding author upon reasonable request.

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 22, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 serostatus of healthcare worker in the Austrian state Vorarlberg between June 2020 and January 2021
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 serostatus of healthcare worker in the Austrian state Vorarlberg between June 2020 and January 2021
Michele Atzl, Axel Muendlein, Thomas Winder, Peter Fraunberger, Eva-Maria Brandtner, Kathrin Geiger, Miriam Klausberger, Mark Duerkop, Lukas Sprenger, Beatrix Mutschlechner, Andreas Volgger, Magdalena Benda, Luciano Severgnini, Johannes B. Jaeger, Heinz Drexel, Alois Lang, Andreas Leiherer
medRxiv 2021.02.19.21252045; doi: https://doi.org/10.1101/2021.02.19.21252045
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
SARS-CoV-2 serostatus of healthcare worker in the Austrian state Vorarlberg between June 2020 and January 2021
Michele Atzl, Axel Muendlein, Thomas Winder, Peter Fraunberger, Eva-Maria Brandtner, Kathrin Geiger, Miriam Klausberger, Mark Duerkop, Lukas Sprenger, Beatrix Mutschlechner, Andreas Volgger, Magdalena Benda, Luciano Severgnini, Johannes B. Jaeger, Heinz Drexel, Alois Lang, Andreas Leiherer
medRxiv 2021.02.19.21252045; doi: https://doi.org/10.1101/2021.02.19.21252045

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Occupational and Environmental Health
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
  • Epidemiology (5216)
  • Forensic Medicine (3)
  • Gastroenterology (194)
  • Genetic and Genomic Medicine (750)
  • Geriatric Medicine (77)
  • Health Economics (212)
  • Health Informatics (694)
  • Health Policy (352)
  • Health Systems and Quality Improvement (223)
  • Hematology (98)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5816)
  • Intensive Care and Critical Care Medicine (356)
  • Medical Education (102)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (758)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (475)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (139)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (854)
  • Public and Global Health (1993)
  • Radiology and Imaging (344)
  • Rehabilitation Medicine and Physical Therapy (157)
  • Respiratory Medicine (283)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (75)
  • Surgery (108)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)